Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Viking Therapeutics, Inc. VKTX

Full chart Compare
Set alert

Price alert · VKTX

All alert types
26.54 USD +0.45 (+1.71%)

Nov 4, 2026, 10:54 AM EST

26.09 Day range 27.55
23.82 52-week range 43.15
YTD
-24.57%
1 year
-23.38%

Financial health

Altman Z-Score

2.16 Grey zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

1 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

C-1 / 5 overall

  • DCF 2
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 2
  • P/E 1
  • P/B 1

Valuation

P/E -11.0×
FY 2016: -1.3×FY 2017: -5.1×FY 2018: -20.1×FY 2019: -22.3×FY 2020: -11.3×FY 2021: -6.6×FY 2022: -10.7×FY 2023: -20.5×FY 2024: -39.8×FY 2025: -11.0×
FY 2016 5y median -11.0× FY 2025
P/S 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
P/B 6.2×
FY 2016: 2.4×FY 2017: 7.8×FY 2018: 1.5×FY 2019: 2.1×FY 2020: 1.7×FY 2021: 1.8×FY 2022: 5.0×FY 2023: 5.0×FY 2024: 5.0×FY 2025: 6.2×
FY 2016 5y median 5.0× FY 2025
P/FCF -14.2×
FY 2016: -1.7×FY 2017: -7.1×FY 2018: -23.5×FY 2019: -23.3×FY 2020: -18.8×FY 2021: -7.5×FY 2022: -14.9×FY 2023: -23.9×FY 2024: -50.0×FY 2025: -14.2×
FY 2016 5y median -14.9× FY 2025
EV/EBITDA -10.6×
FY 2016: -1.8×FY 2017: 226×FY 2018: 89.2×FY 2019: -22.4×FY 2020: -9.7×FY 2021: -6.0×FY 2022: -10.0×FY 2023: -19.9×FY 2024: -39.8×FY 2025: -10.6×
FY 2016 5y median -10.6× FY 2025
EV/Sales 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
FCF Yield -7.0%
FY 2016: -57.2%FY 2017: -14.0%FY 2018: -4.3%FY 2019: -4.3%FY 2020: -5.3%FY 2021: -13.4%FY 2022: -6.7%FY 2023: -4.2%FY 2024: -2.0%FY 2025: -7.0%
FY 2016 5y median -6.7% FY 2025

Profitability

Gross Margin 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
ROE -56.3%
FY 2016: -183.2%FY 2017: -152.8%FY 2018: -7.4%FY 2019: -9.3%FY 2020: -16.2%FY 2021: -27.2%FY 2022: -47.4%FY 2023: -24.7%FY 2024: -12.5%FY 2025: -56.3%
FY 2016 5y median -27.2% FY 2025
ROIC -61.5%
FY 2016: -122.2%FY 2017: -112.7%FY 2018: -8.8%FY 2019: -11.8%FY 2020: -17.4%FY 2021: -27.6%FY 2022: -47.9%FY 2023: -28.8%FY 2024: -17.1%FY 2025: -61.5%
FY 2016 5y median -28.8% FY 2025
ROA -50.2%
FY 2016: -101.3%FY 2017: -93.0%FY 2018: -7.3%FY 2019: -9.1%FY 2020: -15.4%FY 2021: -26.1%FY 2022: -40.9%FY 2023: -23.3%FY 2024: -12.1%FY 2025: -50.2%
FY 2016 5y median -26.1% FY 2025

Growth (YoY)

Revenue 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 FY 2025
Operating Income -160.6%
FY 2016: -15.4%FY 2017: -37.7%FY 2018: -37.2%FY 2019: -24.9%FY 2020: -30.5%FY 2021: -30.5%FY 2022: -26.4%FY 2023: -43.3%FY 2024: -49.7%FY 2025: -160.6%
FY 2016 FY 2025
EPS (diluted) -215.8%
FY 2016: 75.5%FY 2017: 12.2%FY 2018: 51.9%FY 2019: 5.3%FY 2020: -38.9%FY 2021: -40.0%FY 2022: -25.7%FY 2023: -3.4%FY 2024: -11.0%FY 2025: -215.8%
FY 2016 FY 2025
Free Cash Flow -217.4%
FY 2016: -26.8%FY 2017: -33.3%FY 2018: -27.1%FY 2019: -32.0%FY 2020: 12.0%FY 2021: -118.5%FY 2022: -1.7%FY 2023: -51.6%FY 2024: -19.6%FY 2025: -217.4%
FY 2016 FY 2025

Financial Health

Current Ratio 9.3×
FY 2016: 2.2×FY 2017: 2.5×FY 2018: 66.4×FY 2019: 41.8×FY 2020: 21.1×FY 2021: 24.0×FY 2022: 7.6×FY 2023: 19.2×FY 2024: 33.1×FY 2025: 9.3×
FY 2016 5y median 19.2× FY 2025
Quick Ratio 9.3×
FY 2016: 2.2×FY 2017: 2.5×FY 2018: 66.4×FY 2019: 41.8×FY 2020: 21.1×FY 2021: 24.0×FY 2022: 7.6×FY 2023: 19.2×FY 2024: 33.1×FY 2025: 9.3×
FY 2016 5y median 19.2× FY 2025
Debt / Equity 0.0×
FY 2016: 0.4×FY 2017: 0.3×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
Net Debt / EBITDA 0.5×
FY 2016: -0.0×FY 2017: -12.5×FY 2018: -5.3×FY 2019: 0.3×FY 2020: 0.7×FY 2021: 0.5×FY 2022: 0.5×FY 2023: 0.6×FY 2024: 0.2×FY 2025: 0.5×
FY 2016 5y median 0.5× FY 2025
Interest Coverage 0.0×
FY 2016: -6.8×FY 2017: -9.8×FY 2018: -46.5×FY 2019: -224×FY 2020: -402×FY 2021: -3093×FY 2022: -1192×FY 2023: -1146×FY 2024: -1606×FY 2025: 0.0×
FY 2016 5y median -1192× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31